2018
DOI: 10.1016/j.ijpddr.2017.11.004
|View full text |Cite
|
Sign up to set email alerts
|

An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes

Abstract: Parasitic nematodes infect hundreds of millions of people and farmed livestock. Further, plant parasitic nematodes result in major crop damage. The pipeline of therapeutic compounds is limited and parasite resistance to the existing anthelmintic compounds is a global threat. We have developed an INVertebrate Automated Phenotyping Platform (INVAPP) for high-throughput, plate-based chemical screening, and an algorithm (Paragon) which allows screening for compounds that have an effect on motility and development … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
92
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 81 publications
(93 citation statements)
references
References 67 publications
0
92
1
Order By: Relevance
“…So far, the Pathogen Box has been screened against the nematode H. contortus ( Preston et al, 2016 ), the fungi Candida albicans and Cryptococcus neoformans ( Vila and Lopez-Ribot, 2016 ; Mayer and Kronstad, 2017 ), Plasmodium and the kinetoplastids Leishmania and Trypanosoma ( Calit et al, 2018 ; Dennis et al, 2018 ; Duffy et al, 2017 ), Neospora caninum ( Müller et al, 2017 ) , Mycobacterium abscessus and M. avium ( Jeong et al, 2018 ; Low et al, 2017 ), Toxoplasma gondii ( Spalenka et al, 2017 ), C. elegans ( Partridge et al, 2018 ), Entamoeba histolytica ( Mi-Ichi et al, 2018 ), and Giardia lamblia and Cryptosporidium parvum ( Hennessey et al, 2018 ). Interestingly, all compounds that exhibited activity against E. multilocularis were also active against at least one more pathogen other than the one it was selected for by MMV (with the exception of nitazoxanide), thus underlining the importance and potential of the concept of drug repurposing.…”
Section: Discussionmentioning
confidence: 99%
“…So far, the Pathogen Box has been screened against the nematode H. contortus ( Preston et al, 2016 ), the fungi Candida albicans and Cryptococcus neoformans ( Vila and Lopez-Ribot, 2016 ; Mayer and Kronstad, 2017 ), Plasmodium and the kinetoplastids Leishmania and Trypanosoma ( Calit et al, 2018 ; Dennis et al, 2018 ; Duffy et al, 2017 ), Neospora caninum ( Müller et al, 2017 ) , Mycobacterium abscessus and M. avium ( Jeong et al, 2018 ; Low et al, 2017 ), Toxoplasma gondii ( Spalenka et al, 2017 ), C. elegans ( Partridge et al, 2018 ), Entamoeba histolytica ( Mi-Ichi et al, 2018 ), and Giardia lamblia and Cryptosporidium parvum ( Hennessey et al, 2018 ). Interestingly, all compounds that exhibited activity against E. multilocularis were also active against at least one more pathogen other than the one it was selected for by MMV (with the exception of nitazoxanide), thus underlining the importance and potential of the concept of drug repurposing.…”
Section: Discussionmentioning
confidence: 99%
“…An earlier version of this system has been previously described [ 13 , 14 ]. Two hundred frame movies of the whole plate were recorded at 10 frames per second and then motility determined by an algorithm based on thresholding pixel variance over time [ 15 ]. For the hit confirmation and expansion assays, library material was used at a final concentration of 100μM.…”
Section: Methodsmentioning
confidence: 99%
“…Worm movement was stimulated by inserting and removing a 96-well PCR plate into/from the wells of the assay plate, and then whole plate 200 frame movies were recorded at 30 frames per second. Growth was quantified as a correlate of movement using the same automated system described earlier, which estimates movement for each well by categorising pixels as imaging movement if their variance is greater the mean plus one standard deviation of the variances of all the pixels on the plate [ 15 ].…”
Section: Methodsmentioning
confidence: 99%
“…Most studies use only a single target organism, which in many cases is not a parasite (i.e., C. elegans). In vitro evidence of activity on a suitable parasite is probably essential for progressing a compound for further development, although well-documented anthelmintic traditional use, in conjunction with C. elegans activity, gives more confidence that the activity will persist on parasites, compared to compounds emerging from a screen of a chemical library [114,115].…”
Section: Spectrummentioning
confidence: 99%